Science, with a Side of Business

Business and science can seem like two different worlds, and some scientists are now entering joint programs so they can work and speak fluently in both. A number of schools have launched joint PhD/MBA programs in recent years, including Cornell University, San Diego State University, University of California, San Diego, University of Rochester, NY, and Wake Forest University. Business-savvy scientists may give a company a competitive edge or may be the key to a successful startup.Joel Martin ea

Written byAlison McCook
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Business and science can seem like two different worlds, and some scientists are now entering joint programs so they can work and speak fluently in both. A number of schools have launched joint PhD/MBA programs in recent years, including Cornell University, San Diego State University, University of California, San Diego, University of Rochester, NY, and Wake Forest University. Business-savvy scientists may give a company a competitive edge or may be the key to a successful startup.

Joel Martin earned a PhD in chemistry and an MBA, and used the business knowledge when he founded Argonaut Technologies in Redwood City, Calif. The company makes automation equipment for combinatorial chemistry. He again used his knowledge and skills as cofounder of Hayward, Calif.-based Quantum Dot, which sells nanotechnology products.

"It's incredible how much I learned," Martin says. During his companies' early days, he developed the funding pitch, prepared his own budget, and learned ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies